Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?

Behavioural Brain Research

Volumn 223, Issue 2, 2011, Pages 336-341

  Karl, T ^a,b,c   Burne, T H J ^d,e   Van den Buuse, M ^f,g   Chesworth, R ^a,b  

^a SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Genetic mouse model; Neuregulin 1; Prepulse inhibition; Schizophrenia; Sensorimotor gating

Indexed keywords

MEMBRANE PROTEIN; MUTANT PROTEIN; NEU DIFFERENTIATION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE SEVERITY; GENE MUTATION; HABITUATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN DOMAIN; SCHIZOPHRENIA; SENSORIMOTOR GATING DEFICIT; STARTLE REFLEX; WILD TYPE;

ACOUSTIC STIMULATION; ANIMALS; DISEASE MODELS, ANIMAL; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MEMBRANE POTENTIALS; MICE; MUTATION; NEUREGULIN-1; SCHIZOPHRENIA; SENSORY GATING; STARTLE REACTION;

EID: 79959301242     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.04.051     Document Type: Article

References (38)

1. Munafo M.R., Thiselton D.L., Clark T.G., Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 2006, 11:539-546.
2. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002, 71:877-892.
3. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci USA 2006, 103:6747-6752.
4. Kerber G., Streif R., Schwaiger F.W., Kreutzberg G.W., Hager G. Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system. J Mol Neurosci 2003, 21:149-165.
5. Corfas G., Roy K., Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 2004, 7:575-580.
6. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006, 60:132-140.
7. Hong L.E., Wonodi I., Stine O.C., Mitchell B.D., Thaker G.K. Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biol Psychiatry 2008, 63:17-23.
8. Braff D.L., Swerdlow N.R., Geyer M.A. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 1999, 156:596-602.
9. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001, 156:117-154.
10. Varty G.B., Walters N., Cohen-Williams M., Carey G.J. Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur J Pharmacol 2001, 424:27-36.
11. Powell C.M., Miyakawa T. Schizophrenia-relevant behavioural testing in rodent models: a uniquely human disorder?. Biol Psychiatry 2006, 59:1198-1207.
12. Van den Buuse M. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 2010, 36:246-270.
13. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008, 9:437-452.
14. Walss-Bass C., Liu W., Lew D.F., Villegas R., Montero P., Dassori A., et al. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry 2006, 60:548-553.
15. Karl T., Duffy L., Scimone A., Harvey R.P., Schofield P.R. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav 2007, 6:677-687.
16. O'Tuathaigh C.M., Babovic D., O'Sullivan G.J., Clifford J.J., Tighe O., Croke D.T., et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 2007, 147:18-27.
17. Duffy L., Cappas E., Lai D., Boucher A.A., Karl T. Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 2010, 170:800-807.
18. Boucher A.A., Arnold J.C., Duffy L., Schofield P.R., Micheau J., Karl T. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 2007, 192:325-336.
19. Boucher A.A., Hunt G.E., Micheau J., Huang X., McGregor I.S., Karl T., et al. The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. Int J Neuropsychopharmacol 2010, 1-13.
20. Van den Buuse M., Wischhof L., Lee R.X., Martin S., Karl T. Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. Int J Neuropsychopharmacol 2009, 12:1383-1393.
21. Richter S.H., Garner J.P., Wurbel H. Environmental standardization: cure or cause of poor reproducibility n animal experiments?. Nat Methods 2009, 6:257-261.
22. Chen Y., Mao Y., Zhou D., Hu X., Wang J., Ma Y. Environmental enrichment and chronic restraint stress in ICR mice: effects on prepulse inhibition of startle and Y-maze spatial recognition memory. Behav Brain Res 2010, 212:49-55.
23. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 2000, 11:185-204.
24. Wang J.H., Short J., Ledent C., Lawrence A.J., van den Buuse M. Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behav Brain Res 2003, 143:201-207.
25. Boucher A.A., Hunt G.E., Karl T., Micheau J., McGregor I.S., Arnold J.C. Heterozygous neuregulin 1 mice display greater baseline and delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience 2007, 149:861-870.
26. Karl T., Chesworth R., Duffy L., Herzog H. Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency. Behav Brain Res 2010, 207:434-440.
27. Duffy L., Cappas E., Scimone A., Schofield P.R., Karl T. Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. Behav Neurosci 2008, 122:748-759.
28. Chen Y.J., Johnson M.A., Lieberman M.D., Goodchild R.E., Schobel S., Lewandowski N., et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J Neurosci 2008, 28:6872-6883.
29. Deakin I.H., Law A.J., Oliver P.L., Schwab M.H., Nave K.A., Harrison P.J., et al. Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 2009, 20:1523-1528.
30. Wen L., Lu Y.S., Zhu X.H., Li X.M., Woo R.S., Chen Y.J., et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA 2009, 107:1211-1216.
31. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 1998, 95:9991-9996.
32. Ehrlichman R.S., Luminais S.N., White S.L., Rudnick N.D., Ma N., Dow H.C., et al. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res 2009, 1294:116-127.
33. Gerlai R., Pisacane P., Erickson S. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res 2000, 109:219-227.
34. Michailov G.V., Sereda M.W., Brinkmann B.G., Fischer T.M., Haug B., Birchmeier C., et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004, 304:700-703.
35. Rimer M., Barrett D.W., Maldonado M.A., Vock V.M., Gonzalez-Lima F. Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 2005, 16:271-275.
36. Wolpowitz D., Mason T.B., Dietrich P., Mendelsohn M., Talmage D.A., Role L.W. Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron 2000, 25:79-91.
37. Golub M.S., Germann S.L., Lloyd K.C. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav Brain Res 2004, 153:159-170.
38. Thuret S., Alavian K.N., Gassmann M., Lloyd C.K., Smits S.M., Smidt M.P., et al. The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta. J Neurochem 2004, 91:1302-1311.